Dhanuka Agritech Q1 Review - Upbeat Future Outlook Amid Near-Term Challenges: Dolat Capital
BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
Dolat Capital Report
Dhanuka Agritech Ltd. reported a subdued Q1 FY22 performance owing to higher raw material prices, weaker rainfall in June 2021 and lower herbicide consumption.
Sales witnessed a decline of 2.7% YoY to Rs 3.64 billion.
Gross margins stood at 33.7%, down by 50 basis points YoY as input costs soaring higher across the herbicide, insecticide and fungicide pack.
Ebitda margin saw a proportionate decline of 66 bps YoY to 16.8%.
Innovation turnover index too saw a slump to only 9% in Q1 FY22 owing to challenges related to mobility, distribution and expansion coupled with higher sales of generics during the quarter under review.
Dhanuka Agritech's management expects the raw material price trend to be on the higher side.
Click on the attachment to read the full report:
This report is authored by an external party. BloombergQuint does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BloombergQuint.
Users have no license to copy, modify, or distribute the content without permission of the Original Owner.